These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 8758477)

  • 1. [Comparison of four methods for the determination of the susceptibility of 47 strains of Pseudomonas aeruginosa to ceftazidime and cefepime: influence of the choice of interpretative criteria].
    Boucaud-Maître Y; Thoinet S
    Pathol Biol (Paris); 1996 May; 44(5):363-6. PubMed ID: 8758477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in-vitro activities of newer cephalosporins cefclidin, cefepime, and cefpirome against ceftazidime- or imipenem-resistant Pseudomonas aeruginosa.
    Watanabe N; Hiruma R; Katsu K
    J Antimicrob Chemother; 1992 Nov; 30(5):633-41. PubMed ID: 1493980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefepime activity against Pseudomonas aeruginosa: evaluation of Etest and two disc diffusion methods.
    Stes P; Goossens H
    J Antimicrob Chemother; 1996 Oct; 38(4):707-11. PubMed ID: 8937965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the activity of two broad-spectrum cephalosporins tested against 2,299 strains of Pseudomonas aeruginosa isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998.
    Ramphal R; Hoban DJ; Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 2000 Feb; 36(2):125-9. PubMed ID: 10705055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa.
    Aubert D; Poirel L; Chevalier J; Leotard S; Pages JM; Nordmann P
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1615-20. PubMed ID: 11353602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative antimicrobial activity of FK037, cefpirome, ceftazidime and cefepime against aminoglycoside-sensitive and aminoglycoside-resistant Pseudomonas aeruginosa and Pseudomonas spp.
    Baltch AL; Smith RP; Ritz W
    Chemotherapy; 1994; 40(6):391-8. PubMed ID: 7842822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of ceftazidime, cefepime and imipenem on 1,005 Pseudomonas aeruginosa clinical isolates either susceptible or resistant to beta-lactams.
    Bonfiglio G; Marchetti F
    Chemotherapy; 2000; 46(4):229-34. PubMed ID: 10859428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of in vitro resistance of Pseudomonas aeruginosa to cefepime, ceftazidime, and cefotaxime.
    Fung-Tomc J; Huczko E; Pearce M; Kessler RE
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1443-5. PubMed ID: 3143306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities of piperacillin, ceftazidime, cefepime and cefpirome against Pseudomonas aeruginosa strains with intrinsic ticarcillin resistance.
    Bert F; Setbon PG; Lambert-Zechovsky N; Branger C
    Chemotherapy; 1996; 42(6):426-31. PubMed ID: 8957576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of pseudomonas aeruginosa to cefepime versus ceftazidime in patients with cystic fibrosis.
    Robinson CA; Kuhn RJ; Craigmyle J; Anstead MI; Kanga JE
    Pharmacotherapy; 2001 Nov; 21(11):1320-4. PubMed ID: 11714203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of resistance in clinical isolates of Pseudomonas aeruginosa less susceptible to cefepime than to ceftazidime.
    Campo Esquisabel AB; Rodríguez MC; Campo-Sosa AO; Rodríguez C; Martínez-Martínez L
    Clin Microbiol Infect; 2011 Dec; 17(12):1817-22. PubMed ID: 21599797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of resistance in Pseudomonas aeruginosa to broad-spectrum cephalosporins via step-wise mutations.
    Gradelski E; Fung-Tomc J; Huczko E; Kessler RE
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():75-80. PubMed ID: 8150769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of resistance during ceftazidime and cefepime therapy in a murine peritonitis model.
    Pechère JC; Vladoianu IR
    J Antimicrob Chemother; 1992 May; 29(5):563-73. PubMed ID: 1624394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of Pseudomonas aeruginosa isolates to ceftazidime is unrelated to the expression of the outer membrane protein OprC.
    Pérez FJ; Navarro D; Gimeno C; García-de-Lomas J
    Chemotherapy; 1997; 43(1):27-30. PubMed ID: 8996738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nosocomial infections with ceftazidime-resistant Pseudomonas aeruginosa: risk factors and outcome.
    Lee SC; Fung CP; Liu PY; Wang TC; See LC; Lee N; Chen SC; Shieh WB
    Infect Control Hosp Epidemiol; 1999 Mar; 20(3):205-7. PubMed ID: 10100550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of cefepime, ceftazidime, and ceftizoxime against mutants of Enterobacteriaceae and Pseudomonas aeruginosa derepressed for class I beta-lactamase.
    Knapp CC; Washington JA
    J Antimicrob Chemother; 1989 Dec; 24(6):1011-2. PubMed ID: 2516083
    [No Abstract]   [Full Text] [Related]  

  • 17. A propensity score-matched analysis of the impact of minimum inhibitory concentration on mortality in patients with Pseudomonas aeruginosa bacteremia treated with cefepime or ceftazidime.
    Ratliff AR; Gentry CA; Williams RJ
    Diagn Microbiol Infect Dis; 2017 Apr; 87(4):376-381. PubMed ID: 28087171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Criteria for the assessment of susceptibility to ceftazidime using the disc diffusion procedure.
    Grimm H
    Infection; 1983; 11 Suppl 1():S35-8. PubMed ID: 6339416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro activity of six beta-lactams against 295 strains of enterobacteriaceae and P. aeruginosa isolated from neutropenic patients].
    Maugein J; Perrier F; Cony Makhoul P; Fourche J; Darmaillac V
    Pathol Biol (Paris); 1995 Apr; 43(4):253-7. PubMed ID: 7567110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance of Pseudomonas aeruginosa strains isolated from surgical infections in a 7-year period at a general hospital in Venezuela.
    Rodriguez CN; Rodriguez-Morales AJ; Garcia A; Pastran B; Meijomil P
    Surg Infect (Larchmt); 2006 Jun; 7(3):269-73. PubMed ID: 16875460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.